NCT01742299 2026-04-01
Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
Novartis
Phase 4 Active not recruiting
Clinical Trials
61 trialsNCT07486713 2026-03-20
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Rigel Pharmaceuticals
Phase 4 Recruiting
NCT06562543 2026-02-27
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Takeda
Phase 4 Recruiting
NCT04373564 2026-01-22
ODYSSEY
Guerbet
Phase 4 Recruiting
NCT00756509 2026-01-20
Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib
Novartis
Phase 4 Completed
NCT02842749 2025-02-10
Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China
Novartis
Phase 4 Completed
NCT05848947 2025-01-29
MAApping
Sirtex Medical
Phase 4 Completed
NCT04524442 2025-01-24
Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
Advanced Accelerator Applications
Phase 4 Completed
NCT03564938 2024-12-03
Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).
Bayer
Phase 4 Completed
NCT04825574 2024-11-26
Study for Patients Previously Treated in Avapritinib Clinical Trials
Blueprint Medicines Corporation
Phase 4 Completed
NCT05410535 2024-06-28
To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
Daewoong Pharmaceutical Co. LTD.
Phase 4 Completed
NCT01735955 2024-02-08
Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Novartis
Phase 4 Completed
NCT04297254 2023-11-15
A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC
Eisai Inc.
Phase 4 Completed
NCT01468623 2023-07-19
PROFUSE
Myriad Genetic Laboratories, Inc.
Phase 4 Terminated
NCT03859869 2023-06-05
A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)
AbbVie
Phase 4 Terminated
NCT02224456 2022-02-14
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
GlaxoSmithKline
Phase 4 Completed
NCT04315311 2021-11-08
Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer
AbbVie
Phase 4 Withdrawn
NCT02444572 2021-07-29
ENOXACARE
Les Laboratoires des Médicaments Stériles
Phase 4 Completed
NCT00510354 2020-09-10
Radix
Novartis
Phase 4 Completed
NCT02638584 2020-07-31
Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.
Il-Yang Pharm. Co., Ltd.
Phase 4 Completed
NCT01760616 2020-03-06
Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
Qidong Gaitianli Medicines Co., Ltd
Phase 4 Terminated
NCT02301962 2019-12-16
Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer
Dr. Reddy's Laboratories Limited
Phase 4 Unknown
NCT00140894 2019-09-20
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT01806740 2019-08-08
DCE-MRI
Guerbet
Phase 4 Terminated
NCT01525550 2019-07-30
A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
Pfizer
Phase 4 Completed
NCT03550482 2019-06-05
Oncoxin® and Quality of Life in Cancer Patients
Catalysis SL
Phase 4 Completed
NCT01588990 2019-01-22
ASCENT
Hoffmann-La Roche
Phase 4 Completed
NCT01770431 2017-10-02
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy
Qidong Gaitianli Medicines Co., Ltd
Phase 4 Completed
NCT01639703 2017-07-13
Hepatic Xenetix-CT Perfusion
Guerbet
Phase 4 Completed
NCT01695772 2017-06-09
A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT01959061 2017-03-13
TACE
Nanjing Chia-tai Tianqing Pharmaceutical
Phase 4 Unknown
NCT02582970 2017-03-09
A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum
Hoffmann-La Roche
Phase 4 Completed
NCT00510627 2017-03-03
Prometheus
Boston Scientific Corporation
Phase 4 Withdrawn
NCT01260194 2016-11-02
A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer
Hoffmann-La Roche
Phase 4 Terminated
NCT02567331 2016-11-02
A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT02581423 2016-11-02
A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT01041612 2016-10-21
Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi
Taewoong Medical Co., Ltd.
Phase 4 Completed
NCT00642733 2016-08-24
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Hoffmann-La Roche
Phase 4 Terminated
NCT00793871 2015-11-20
GIST
Pfizer
Phase 4 Completed
NCT00754468 2015-11-04
ESODOI
CSA Medical, Inc.
Phase 4 Completed
NCT00502671 2015-09-03
A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.
Hoffmann-La Roche
Phase 4 Completed
NCT00577031 2015-08-18
OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
Hoffmann-La Roche
Phase 4 Completed
NCT01689792 2015-03-31
A Multi-centre Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREP®) Versus a Hyperosmotic and Stimulant Combined Low Volume Bowel Preparation (Sodium Picosulfate and Magnesium Citrate)
Norgine
Phase 4 Completed
NCT01706822 2015-03-18
Radial Reload Laparoscopic LAR Case Series
Medtronic - MITG
Phase 4 Terminated
NCT00764621 2014-11-04
Health Economic Evaluation of Primovist-enhanced Liver MRI
Bayer
Phase 4 Completed
NCT00526786 2014-03-14
ICE
CSA Medical, Inc.
Phase 4 Terminated
NCT01098760 2013-10-31
HATT
Bayer
Phase 4 Completed
NCT01894828 2013-07-10
Nutritional Supplementation in Patients With no Signs of Malnutrition
MedSource Polska
Phase 4 Unknown
NCT01401075 2012-11-07
RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients
Abnoba Gmbh
Phase 4 Completed
NCT00171977 2012-08-07
Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)
Novartis
Phase 4 Completed